Gavin assists clients in patent matters in New Zealand and overseas. His broad technical background in biochemistry and chemistry enables him to quickly understand a client’s technology, particularly in the chemistry-biology interface.
Gavin joined AJ Park in 2022 from a leading UK and European patent firm where he worked as a UK and European patent attorney.
Gavin has a particular interest and expertise in working with biotech and pharmaceutical start-ups to assess freedom-to-operate issues and develop patent portfolios that help them secure investment, build product pipelines, and move their products to market. He is particularly interested in inventions relating to drug repurposing, protein therapeutics, vaccines, and cell-based therapies.
Prior to joining the patent profession, Gavin worked as a research scientist in biotherapeutic drug discovery for an international pharmaceutical company. During this time, he worked on numerous drug discovery projects focused on developing new botulinum neurotoxin-based therapeutics. His research led to the selection of two clinical candidates. He is also an inventor on several patent families.
Outside of work, Gavin enjoys exploring Auckland’s parks and beaches with his partner and 4-year-old daughter.
- PhD (Chemical Biology), University of Nottingham
- BSc. (Biochemistry and Biological Chemistry), University of Nottingham
- Postgraduate Certificate in Intellectual property, Queen Mary University of London
- Chartered UK & European Patent Attorney
Dr Gavin Hackett's insights
Article \ 14 Nov 2022
The launch: The Unitary Patent and the Unified Patent Court
Significant changes are being made to the European patent system, and they will impact all European patent holders. In this article, we cover opting out during the sunrise period, what European patent holders need to consider, and more importantly, what they need to action.